290 related articles for article (PubMed ID: 28610401)
21. Familial non-multiple endocrine neoplasia medullary thyroid carcinoma: report of a case confirming a new clinical entity in Japan.
Katagiri M; Ohtawa T; Ito K; Harada T
Surg Today; 1995; 25(9):822-6. PubMed ID: 8555702
[TBL] [Abstract][Full Text] [Related]
22. RET oncogene mutations in medullary thyroid carcinoma in Mexican families.
González B; Salcedo M; Medrano ME; Mantilla A; Quiñónez G; Benítez-Bribiesca L; Rodríguez-Cuevas S; Cabrera L; de León B; Altamirano N; Tapia J; Dawson B
Arch Med Res; 2003; 34(1):41-9. PubMed ID: 12604374
[TBL] [Abstract][Full Text] [Related]
23. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
24. Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.
Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Pfragner R; Behmel A; Lorenzo MJ
Genes Chromosomes Cancer; 1995 Mar; 12(3):209-12. PubMed ID: 7536460
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
[TBL] [Abstract][Full Text] [Related]
26. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
27. Update on the cytologic and molecular features of medullary thyroid carcinoma.
Pusztaszeri MP; Bongiovanni M; Faquin WC
Adv Anat Pathol; 2014 Jan; 21(1):26-35. PubMed ID: 24316908
[TBL] [Abstract][Full Text] [Related]
28. Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
Barletta JA; Nosé V; Sadow PM
Endocr Pathol; 2021 Mar; 32(1):35-43. PubMed ID: 33492588
[TBL] [Abstract][Full Text] [Related]
29. Multiple endocrine neoplasia, the old and the new: a mini review.
Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
[TBL] [Abstract][Full Text] [Related]
30. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.
Leboulleux S; Travagli JP; Caillou B; Laplanche A; Bidart JM; Schlumberger M; Baudin E
Cancer; 2002 Jan; 94(1):44-50. PubMed ID: 11815959
[TBL] [Abstract][Full Text] [Related]
31. Differentiated and medullary thyroid cancer in childhood and adolescence.
La Quaglia MP; Telander RL
Semin Pediatr Surg; 1997 Feb; 6(1):42-9. PubMed ID: 9117274
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A.
Machens A; Dralle H
J Clin Endocrinol Metab; 2015 Jul; 100(7):2539-45. PubMed ID: 25946031
[TBL] [Abstract][Full Text] [Related]
33. [Neural crest and multiple endocrinopathies].
Pasini A; Michiels FM; Chappuis-Flament S; Geneste O; Rossel M; Fournier L; Feunteun J; Lenoir G; Schuffenecker I; Billaud M
C R Seances Soc Biol Fil; 1996; 190(5-6):557-67. PubMed ID: 9074721
[TBL] [Abstract][Full Text] [Related]
34. Medullary thyroid carcinoma in children.
Viola D; Romei C; Elisei R
Endocr Dev; 2014; 26():202-13. PubMed ID: 25231454
[TBL] [Abstract][Full Text] [Related]
35. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract][Full Text] [Related]
36. Advanced medullary thyroid cancer: pathophysiology and management.
Ferreira CV; Siqueira DR; Ceolin L; Maia AL
Cancer Manag Res; 2013; 5():57-66. PubMed ID: 23696715
[TBL] [Abstract][Full Text] [Related]
37. Surgical aspects and controversies in the management of medullary thyroid cancer.
Green K; Hintze J; O'Neill JP
Ir J Med Sci; 2022 Dec; 191(6):2461-2466. PubMed ID: 35064534
[TBL] [Abstract][Full Text] [Related]
38. Signaling pathways in follicular cell-derived thyroid carcinomas (review).
Romitti M; Ceolin L; Siqueira DR; Ferreira CV; Wajner SM; Maia AL
Int J Oncol; 2013 Jan; 42(1):19-28. PubMed ID: 23128507
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and genetic profile of patients with medullary thyroid cancer treated in the Cancer Centre--Institute of Oncology in Warsaw].
Czetwertyńska M; Kozłowicz-Gudzińska I; Stachlewska-Nasfeter E; Sromek M; Skasko E; Paszko Z
Endokrynol Pol; 2006; 57(4):415-9. PubMed ID: 17006846
[TBL] [Abstract][Full Text] [Related]
40. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]